Boston Partners Sells 3,083,663 Shares of R1 RCM Inc. (NASDAQ:RCM)

Boston Partners lessened its holdings in R1 RCM Inc. (NASDAQ:RCMFree Report) by 96.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 99,652 shares of the healthcare provider’s stock after selling 3,083,663 shares during the quarter. Boston Partners’ holdings in R1 RCM were worth $1,502,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of RCM. Captrust Financial Advisors grew its position in shares of R1 RCM by 81.7% during the 2nd quarter. Captrust Financial Advisors now owns 1,664 shares of the healthcare provider’s stock valued at $35,000 after acquiring an additional 748 shares during the period. Covestor Ltd increased its position in shares of R1 RCM by 313.0% in the second quarter. Covestor Ltd now owns 2,185 shares of the healthcare provider’s stock valued at $41,000 after buying an additional 1,656 shares in the last quarter. Point72 Middle East FZE acquired a new position in shares of R1 RCM during the 4th quarter worth approximately $29,000. State of Wyoming raised its stake in shares of R1 RCM by 29.6% during the 2nd quarter. State of Wyoming now owns 3,333 shares of the healthcare provider’s stock worth $61,000 after buying an additional 762 shares during the period. Finally, Macquarie Group Ltd. lifted its position in shares of R1 RCM by 11.0% during the 2nd quarter. Macquarie Group Ltd. now owns 4,159 shares of the healthcare provider’s stock valued at $88,000 after buying an additional 411 shares in the last quarter. 61.10% of the stock is owned by hedge funds and other institutional investors.

R1 RCM Stock Down 1.5 %

RCM opened at $10.35 on Wednesday. The company has a market cap of $4.34 billion, a PE ratio of -114.99, a P/E/G ratio of 3.44 and a beta of 0.74. The business has a 50 day moving average price of $10.32 and a two-hundred day moving average price of $12.92. R1 RCM Inc. has a 52 week low of $8.87 and a 52 week high of $18.70. The company has a quick ratio of 1.89, a current ratio of 1.89 and a debt-to-equity ratio of 0.60.

Analyst Ratings Changes

Several research firms have issued reports on RCM. Canaccord Genuity Group reaffirmed a “buy” rating and set a $17.00 price objective on shares of R1 RCM in a report on Thursday, December 7th. TheStreet lowered R1 RCM from a “c-” rating to a “d+” rating in a research note on Friday, November 3rd. Barclays began coverage on R1 RCM in a research report on Wednesday, January 3rd. They issued an “overweight” rating and a $14.00 target price on the stock. Royal Bank of Canada reissued an “outperform” rating and issued a $19.00 price objective on shares of R1 RCM in a research note on Thursday, December 7th. Finally, Truist Financial upgraded R1 RCM from a “hold” rating to a “buy” rating and set a $18.00 price objective on the stock in a report on Thursday, October 19th. One research analyst has rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, R1 RCM has a consensus rating of “Moderate Buy” and an average price target of $18.00.

Read Our Latest Report on R1 RCM

R1 RCM Profile

(Free Report)

R1 RCM Inc provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and physician groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers.

Featured Articles

Want to see what other hedge funds are holding RCM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for R1 RCM Inc. (NASDAQ:RCMFree Report).

Institutional Ownership by Quarter for R1 RCM (NASDAQ:RCM)

Receive News & Ratings for R1 RCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for R1 RCM and related companies with MarketBeat.com's FREE daily email newsletter.